Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement

11 Nov 2014 14:08

RNS Number : 7294W
Mobeus Income & Growth 4 VCT PLC
11 November 2014
 



Mobeus Income & Growth 4 VCT plc (the Company)

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2014

 

In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority, Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 30 September 2014. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE (NAV) AND TOTAL RETURN PER SHARE

At 30 September 2014

At 30 June 2014

Net assets attributable to shareholders

£48,468,302

£52,878,546

Shares in issue

42,690,195

41,872,204

Net asset value (NAV) per share

113.53*p

126.29p

Cumulative dividends paid

52.20 p

38.20 p

Total return (net asset value basis) per share since inception

165.73p

164.49p

 

\* The fall in the NAV per share of 12.96 pence is mainly due above to the payment of the interim dividend of 14.00 pence per share, detailed below.

 

CUMULATIVE DIVIDENDS

 

The Company paid an interim dividend of 14.00 pence per share (comprising 12.00 pence from capital and 2.00 pence from income) on 12 September 2014, bringing cumulative dividends paid per share to date to 52.20 pence.

 

NEW INVESTMENT

 

In July 2014, the Company completed a new investment of £1.16 million to support the MBO of Tharstern Limited, the UK's leading supplier of software-based management information systems to the print sector.

 

DIVESTMENTS

 

The VCT completed the full realisation of its investment in DiGiCo Global Limited in July 2014 through a sale to a new professional audio group backed by Electra Partners, generating net cash proceeds of £1.73 million. The total proceeds received by the VCT over the life of this investment of £5.49 million represent a return on investment of 5.49 times original cost of £1.00 million.

 

Following the period-end, the VCT has realised its investments in Focus Pharma Holdings Limited and Youngman Group Limited for net cash proceeds of £1.53 million and £0.81 million respectively. The Company received total proceeds over the life of its investment in

Focus of £2.88 million, representing a return of 3.74 times original cost of £0.77 million. Similarly, over the life of the investment in Youngman, total proceeds of £1.21 million were generated, representing a return of 2.42 times original cost of £0.50 million

 

LOAN STOCK REPAYMENTS

 

A total of £0.15 million has been received in loan stock repayments during the quarter to 30 September 2014, including payments from Tessella Holdings Limited, Westway Services Holdings (2010) Limited and Virgin Wines Holding Company Limited. 

 

A further £0.05 million was received from Fullfield Limited (Motorclean) and Tharstern Limited following the period-end.

 

SHARE BUY-BACKS

 

The Company did not buy back any of its own shares during the quarter ended 30 September 2014. After the period, on 1 October 2014, 110,000 shares were bought back for cancellation. Following this repurchase of shares, there were 42,580,195 Ordinary shares in issue.

 

FUNDRAISING

 

The Company has announced its intention to launch an offer for subscription later this year to raise up to £6 million.

 

The offer will be promoted by Mobeus Equity Partners LLP, the investment adviser to the Company, and will be made alongside similar offers from Mobeus Income & Growth VCT plc, Mobeus Income & Growth 2 VCT plc and The Income & Growth VCT plc.

 

 

For further information, please contact:

Jonathan McGuire, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZFLFFZFFBFBQ
Date   Source Headline
26th Mar 201912:33 pmRNSAnnual Financial Report
20th Mar 20194:07 pmRNSAnnual Results for the year ended 31 December 2018
20th Dec 201810:13 amRNSTransaction in Own Shares
26th Nov 20189:23 amRNSTransaction in Own Shares
16th Nov 20189:55 amRNSInterim Management Statement - 3rd Quarter Results
27th Sep 201811:11 amRNSTransaction in Own Shares
15th Aug 20185:09 pmRNSSubmission to the NSM
14th Aug 201811:37 amRNSDividend Investment Scheme - Suspension
14th Aug 201811:15 amRNSDividend Investment Scheme - Suspension
14th Aug 201810:39 amRNSHalf-year Report
20th Jun 201810:31 amRNSIssue of Equity
6th Jun 20189:33 amRNSTransaction in Own Shares
11th May 20182:34 pmRNSInterim Management Statement
11th May 20182:30 pmRNSResult of AGM
11th May 20182:26 pmRNSDividend Declaration
26th Mar 20188:50 amRNSTransaction in Own Shares
22nd Mar 20182:37 pmRNSAnnual Financial Report
20th Mar 20185:39 pmRNSAnnual Financial Report
13th Mar 20184:33 pmRNSIssue of Equity
25th Jan 201812:02 pmRNSIssue of Equity
5th Jan 201812:40 pmRNSRealisation of Investment in Gro-Group
5th Jan 201811:23 amRNSTotal Voting Rights
21st Dec 20174:33 pmRNSIssue of Equity
21st Dec 201711:49 amRNSTransaction in Own Shares
20th Dec 20171:57 pmRNSPublication of Suppl.Prospcts
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:14 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:11 amRNSJoint Announcement - Fundraising Update
22nd Nov 20179:30 amRNSIssue of Equity
21st Nov 20175:12 pmRNSDividend Declaration
21st Nov 201710:02 amRNSIssue of Equity
16th Nov 20172:01 pmRNSInterim Management Statement
10th Nov 201710:27 amRNSIssue of Equity
1st Nov 201712:44 pmRNSIncrease in Offer size. Expiry of early incentive.
20th Oct 20172:24 pmRNSDirector/PDMR Shareholding
20th Oct 20172:22 pmRNSIssue of Equity
13th Oct 20172:48 pmRNSDecision to utilise over-allotment facility
29th Sep 201710:24 amRNSDirector/PDMR Shareholding - Replacement
29th Sep 20179:18 amRNSDirector/PDMR Shareholding
29th Sep 20179:17 amRNSIssue of Equity
18th Sep 20179:09 amRNSTransaction in Own Shares
11th Sep 20174:35 pmRNSIssue of Equity
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
8th Aug 20175:34 pmRNSHalf-year Report
8th Aug 20173:53 pmRNSHalf-year Report
4th Aug 20175:10 pmRNSJoint Announcement - Fundraising Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.